Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.

Saved in:
Bibliographic Details
Title: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
Authors: Ferreira JP; Centre d'Investigations Cliniques Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.; UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal., Blatchford JP; Elderbrook Solutions GmbH, Sky Tower, Borsigstr. 4, D-74321 Bietigheim-Bissingen, Germany on behalf of Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany., Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco, CA, USA., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA., Angermann CE; Comprehensive Heart Failure Center Würzburg, Department of Medicine 1, University Hospital Würzburg, Würzburg, Germany., Biegus J; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA., Tromp J; Saw Swee Hock School of Public Health, National University of Singapore, the National University Health System, Singapore, Singapore., Nassif ME; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA., Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA., Comin-Colet J; Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL and CIBERCV, Barcelona, Spain., Mentz RJ; Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, NC, USA., Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany., Nordaby M; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Voors AA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Source: European journal of heart failure [Eur J Heart Fail] 2024 Sep; Vol. 26 (9), pp. 1976-1983. Date of Electronic Publication: 2024 Jul 09.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38980272
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ferreira+JP%22">Ferreira JP</searchLink>; Centre d'Investigations Cliniques Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France.; UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Blatchford+JP%22">Blatchford JP</searchLink>; Elderbrook Solutions GmbH, Sky Tower, Borsigstr. 4, D-74321 Bietigheim-Bissingen, Germany on behalf of Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Teerlink+JR%22">Teerlink JR</searchLink>; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kosiborod+MN%22">Kosiborod MN</searchLink>; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Angermann+CE%22">Angermann CE</searchLink>; Comprehensive Heart Failure Center Würzburg, Department of Medicine 1, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Biegus+J%22">Biegus J</searchLink>; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Collins+SP%22">Collins SP</searchLink>; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Tromp+J%22">Tromp J</searchLink>; Saw Swee Hock School of Public Health, National University of Singapore, the National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Nassif+ME%22">Nassif ME</searchLink>; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Psotka+MA%22">Psotka MA</searchLink>; Inova Heart and Vascular Institute, Falls Church, VA, USA.<br /><searchLink fieldCode="AU" term="%22Comin-Colet+J%22">Comin-Colet J</searchLink>; Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL and CIBERCV, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mentz+RJ%22">Mentz RJ</searchLink>; Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Brueckmann+M%22">Brueckmann M</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Nordaby+M%22">Nordaby M</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Ponikowski+P%22">Ponikowski P</searchLink>; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887595%22">European journal of heart failure</searchLink> [Eur J Heart Fail] 2024 Sep; Vol. 26 (9), pp. 1976-1983. <i>Date of Electronic Publication: </i>2024 Jul 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0844 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213889842%22">13889842 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Heart Fail <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38980272
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ejhf.3369
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1976
    Titles:
      – TitleFull: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferreira JP
      – PersonEntity:
          Name:
            NameFull: Blatchford JP
      – PersonEntity:
          Name:
            NameFull: Teerlink JR
      – PersonEntity:
          Name:
            NameFull: Kosiborod MN
      – PersonEntity:
          Name:
            NameFull: Angermann CE
      – PersonEntity:
          Name:
            NameFull: Biegus J
      – PersonEntity:
          Name:
            NameFull: Collins SP
      – PersonEntity:
          Name:
            NameFull: Tromp J
      – PersonEntity:
          Name:
            NameFull: Nassif ME
      – PersonEntity:
          Name:
            NameFull: Psotka MA
      – PersonEntity:
          Name:
            NameFull: Comin-Colet J
      – PersonEntity:
          Name:
            NameFull: Mentz RJ
      – PersonEntity:
          Name:
            NameFull: Brueckmann M
      – PersonEntity:
          Name:
            NameFull: Nordaby M
      – PersonEntity:
          Name:
            NameFull: Ponikowski P
      – PersonEntity:
          Name:
            NameFull: Voors AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0844
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: European journal of heart failure
              Type: main
ResultId 1